Seralutinib clinical trials

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

This study is looking into the long-term safety and effectiveness of an inhaled medicine called seralutinib for adults with pulmonary arterial hypertension (PAH). Participants have already tried seralutinib in an earlier study and will continue to take it.